Aaron E. Miller, MD, Elected to American Academy of Neurology Board

Aaron E. Miller, MD, internationally known multiple sclerosis (MS) clinician, has been elected to the Board of Directors of the American Academy of Neurology (AAN).

New York, NY
 – June 1, 2009 /Press Release/  –– 

Aaron E. Miller, MD, internationally known multiple sclerosis (MS) clinician, has been elected to the Board of Directors of the American Academy of Neurology (AAN). Dr. Miller is the Medical Director of the Corinne Goldsmith Dickinson (CGD) Center for MS and Professor of Neurology at Mount Sinai School of Medicine.

The AAN is the largest and most prestigious international medical association in the field of neurology and neuroscience, with more than 21,000 professional members dedicated to diagnosing, treating, and managing disorders of the brain and nervous system including multiple sclerosis, stroke, Alzheimer’s disease, and others.

"I’m very honored to be joining the eight other Board members and the AAN officers in helping the American Academy of Neurology to fulfill its mission to promote the highest quality patient-centered neurologic care and enhance member career satisfaction," Dr. Miller said. "I’m also very flattered and pleased that through this election process, my work with the AAN over the years has been recognized by my colleagues."

Dr. Miller has been deeply involved with the organization throughout his career. In 1996, he was selected to serve as the Academy’s first chairman of its multiple sclerosis section. He previously served in other AAN leadership positions including Chair of the Program Accreditation & Development Subcommittee, Chair of the Annual Meeting Subcommittee, and Co-Chair of the Education Committee. For the past six years, he has served as Editor of Continuum, the Academy’s bimonthly continuing education journal.

Dr. Miller joined the CGD Center for MS in 2004. Before joining Mount Sinai, he headed the division of Neurology at Maimonides Medical Center in Brooklyn, New York, for 23 years. He continues to serve as co-director of the MS Care Center there. He has served since 2001 as the Chairman of the National Clinical Advisory Board and Chief Medical Officer of the National Multiple Sclerosis Society. He formerly served as President of the Consortium of Multiple Sclerosis Centers. Currently, he is also principal investigator for several ongoing trials of new experimental treatments at the CGD Center, which allows patients access to groundbreaking therapies that are not widely available.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.